{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T04:44:17Z","timestamp":1792557857578,"version":"4.5.0"},"reference-count":47,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2022,11,11]],"date-time":"2022-11-11T00:00:00Z","timestamp":1668124800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2022,11,11]],"date-time":"2022-11-11T00:00:00Z","timestamp":1668124800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100016321","name":"First Clinical Medical School, Lanzhou University","doi-asserted-by":"publisher","award":["2020-ZD-68"],"award-info":[{"award-number":["2020-ZD-68"]}],"id":[{"id":"10.13039\/501100016321","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Transl Oncol"],"DOI":"10.1007\/s12094-022-02990-w","type":"journal-article","created":{"date-parts":[[2022,11,11]],"date-time":"2022-11-11T18:02:55Z","timestamp":1668189775000},"page":"384-395","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Mechanism of salidroside in the treatment of chronic myeloid leukemia based on the network pharmacology and molecular docking"],"prefix":"10.1007","volume":"25","author":[{"given":"Yihong","family":"Chai","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Feng","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zijian","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Panpan","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qi","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenling","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7473-7561","authenticated-orcid":false,"given":"Yaming","family":"Xi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,11,11]]},"reference":[{"issue":"10","key":"2990_CR1","first-page":"430","volume":"69","author":"N Thielen","year":"2011","unstructured":"Thielen N, Ossenkoppele GJ, Schuurhuis GJ, Janssen JJ. New insights into the pathogenesis of chronic myeloid leukaemia: towards a path to cure. Neth J Med. 2011;69(10):430\u201340.","journal-title":"Neth J Med"},{"issue":"7","key":"2990_CR2","doi-asserted-by":"publisher","first-page":"2254","DOI":"10.1172\/JCI41246","volume":"120","author":"D Perrotti","year":"2010","unstructured":"Perrotti D, Jamieson C, Goldman J, Skorski T. Chronic myeloid leukemia: mechanisms of blastic transformation. J Clin Invest. 2010;120(7):2254\u201364. https:\/\/doi.org\/10.1172\/JCI41246.","journal-title":"J Clin Invest"},{"key":"2990_CR3","doi-asserted-by":"publisher","first-page":"825","DOI":"10.2147\/DDDT.S191303","volume":"13","author":"S Flis","year":"2019","unstructured":"Flis S, Chojnacki T. Chronic myelogenous leukemia, a still unsolved problem: pitfalls and new therapeutic possibilities. Drug Des Devel Ther. 2019;13:825\u201343. https:\/\/doi.org\/10.2147\/DDDT.S191303.","journal-title":"Drug Des Devel Ther"},{"key":"2990_CR4","doi-asserted-by":"publisher","DOI":"10.3389\/fgene.2021.742802","author":"M Amir","year":"2021","unstructured":"Amir M, Javed S. A review on the therapeutic role of TKIs in case of CML in combination with epigenetic drugs. Front Genet. 2021. https:\/\/doi.org\/10.3389\/fgene.2021.742802.","journal-title":"Front Genet"},{"issue":"5","key":"2990_CR5","doi-asserted-by":"publisher","first-page":"448","DOI":"10.1007\/s11899-021-00655-z","volume":"16","author":"HR Wolfe","year":"2021","unstructured":"Wolfe HR, Rein LAM. The evolving landscape of frontline therapy in chronic phase chronic myeloid leukemia (CML). Curr Hematol Malig Rep. 2021;16(5):448\u201354. https:\/\/doi.org\/10.1007\/s11899-021-00655-z.","journal-title":"Curr Hematol Malig Rep"},{"key":"2990_CR6","doi-asserted-by":"publisher","first-page":"77","DOI":"10.3389\/fphar.2016.00077","volume":"7","author":"H Li","year":"2016","unstructured":"Li H, Li M, Wang G, et al. EM23, a natural sesquiterpene lactone from elephantopus mollis, induces apoptosis in human myeloid leukemia cells through thioredoxin- and reactive oxygen species-mediated signaling pathways. Front Pharmacol. 2016;7:77. https:\/\/doi.org\/10.3389\/fphar.2016.00077.","journal-title":"Front Pharmacol"},{"issue":"1","key":"2990_CR7","doi-asserted-by":"publisher","first-page":"e2014005","DOI":"10.4084\/MJHID.2014.005","volume":"6","author":"M Baccarani","year":"2014","unstructured":"Baccarani M, Castagnetti F, Gugliotta G, Palandri F, Rosti G. Treatment recommendations for chronic myeloid leukemia. Mediterr J Hematol Infect Dis. 2014;6(1):e2014005. https:\/\/doi.org\/10.4084\/MJHID.2014.005.","journal-title":"Mediterr J Hematol Infect Dis"},{"issue":"3","key":"2990_CR8","doi-asserted-by":"publisher","first-page":"207","DOI":"10.4103\/0971-5851.142036","volume":"35","author":"A Gupta","year":"2014","unstructured":"Gupta A, Khattry N. Current status of hematopoietic stem cell transplant in chronic myeloid leukemia. Indian J Med Paediatr Oncol. 2014;35(3):207\u201310. https:\/\/doi.org\/10.4103\/0971-5851.142036.","journal-title":"Indian J Med Paediatr Oncol"},{"key":"2990_CR9","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2020.568423","author":"Z Xie","year":"2020","unstructured":"Xie Z, Lu H, Yang S, et al. Salidroside attenuates cognitive dysfunction in senescence-accelerated mouse prone 8 (SAMP8) mice and modulates inflammation of the gut-brain axis. Front Pharmacol. 2020. https:\/\/doi.org\/10.3389\/fphar.2020.568423.","journal-title":"Front Pharmacol"},{"key":"2990_CR10","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1016\/j.brainresbull.2020.08.009","volume":"164","author":"Y Wu","year":"2020","unstructured":"Wu Y, Wang Y, Wu Y, Li T, Wang W. Salidroside shows anticonvulsant and neuroprotective effects by activating the Nrf2-ARE pathway in a pentylenetetrazol-kindling epileptic model. Brain Res Bull. 2020;164:14\u201320. https:\/\/doi.org\/10.1016\/j.brainresbull.2020.08.009.","journal-title":"Brain Res Bull"},{"key":"2990_CR11","doi-asserted-by":"publisher","DOI":"10.1016\/j.cbi.2020.109268","author":"X Zhang","year":"2021","unstructured":"Zhang X, Xie L, Long J, et al. Salidroside: a review of its recent advances in synthetic pathways and pharmacological properties. Chem Biol Interact. 2021. https:\/\/doi.org\/10.1016\/j.cbi.2020.109268.","journal-title":"Chem Biol Interact"},{"issue":"1","key":"2990_CR12","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1186\/s12906-018-2120-1","volume":"18","author":"H Li","year":"2018","unstructured":"Li H, Chen C. Correction to: Inhibition of autophagy enhances synergistic effects of Salidroside and anti-tumor agents against colorectal cancer. BMC Complement Altern Med. 2018;18(1):72. https:\/\/doi.org\/10.1186\/s12906-018-2120-1.","journal-title":"BMC Complement Altern Med"},{"issue":"3","key":"2990_CR13","doi-asserted-by":"publisher","first-page":"3162","DOI":"10.3892\/ol.2018.8982","volume":"16","author":"T Li","year":"2018","unstructured":"Li T, Xu K, Liu Y. Anticancer effect of salidroside reduces viability through autophagy\/PI3K\/Akt and MMP-9 signaling pathways in human bladder cancer cells. Oncol Lett. 2018;16(3):3162\u20138. https:\/\/doi.org\/10.3892\/ol.2018.8982.","journal-title":"Oncol Lett"},{"key":"2990_CR14","doi-asserted-by":"publisher","DOI":"10.1016\/j.lfs.2022.120737","author":"H Li","year":"2022","unstructured":"Li H, Huang D, Hang S. Retraction notice to \"Salidroside inhibits the growth, migration and invasion of Wilms\u2019 tumor cells through down-regulation of miR-891b. Life Sci. 2022. https:\/\/doi.org\/10.1016\/j.lfs.2022.120737.","journal-title":"Life Sci"},{"issue":"1","key":"2990_CR15","doi-asserted-by":"publisher","first-page":"3500","DOI":"10.1080\/21691401.2019.1652626","volume":"47","author":"L Yang","year":"2019","unstructured":"Yang L, Yu Y, Zhang Q, et al. Anti-gastric cancer effect of Salidroside through elevating miR-99a expression. Artif Cells Nanomed Biotechnol. 2019;47(1):3500\u201310. https:\/\/doi.org\/10.1080\/21691401.2019.1652626.","journal-title":"Artif Cells Nanomed Biotechnol"},{"issue":"1","key":"2990_CR16","doi-asserted-by":"publisher","first-page":"1014","DOI":"10.1080\/21691401.2019.1584566","volume":"47","author":"M Ren","year":"2019","unstructured":"Ren M, Xu W, Xu T. Salidroside represses proliferation, migration and invasion of human lung cancer cells through AKT and MEK\/ERK signal pathway. Artif Cells Nanomed Biotechnol. 2019;47(1):1014\u201321. https:\/\/doi.org\/10.1080\/21691401.2019.1584566.","journal-title":"Artif Cells Nanomed Biotechnol"},{"issue":"3","key":"2990_CR17","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1208\/s12249-019-1523-8","volume":"21","author":"X Yu","year":"2020","unstructured":"Yu X, Sun L, Tan L, et al. Preparation and characterization of PLGA-PEG-PLGA nanoparticles containing salidroside and tamoxifen for breast cancer therapy. AAPS PharmSciTech. 2020;21(3):85. https:\/\/doi.org\/10.1208\/s12249-019-1523-8.","journal-title":"AAPS PharmSciTech"},{"issue":"5","key":"2990_CR18","doi-asserted-by":"publisher","first-page":"6513","DOI":"10.3892\/ol.2018.8090","volume":"15","author":"G Yu","year":"2018","unstructured":"Yu G, Li N, Zhao Y, Wang W, Feng XL. Salidroside induces apoptosis in human ovarian cancer SKOV3 and A2780 cells through the p53 signaling pathway. Oncol Lett. 2018;15(5):6513\u20138. https:\/\/doi.org\/10.3892\/ol.2018.8090.","journal-title":"Oncol Lett"},{"issue":"17","key":"2990_CR19","doi-asserted-by":"publisher","first-page":"5349","DOI":"10.26355\/eurrev_202109_26641","volume":"25","author":"XP Wang","year":"2021","unstructured":"Wang XP, Yuan DY, Tian Y, Li WH. Multiple mechanisms of salidroside on anti-tumor effects. Eur Rev Med Pharmacol Sci. 2021;25(17):5349\u201354. https:\/\/doi.org\/10.26355\/eurrev_202109_26641.","journal-title":"Eur Rev Med Pharmacol Sci"},{"issue":"11","key":"2990_CR20","doi-asserted-by":"publisher","first-page":"682","DOI":"10.1038\/nchembio.118","volume":"4","author":"AL Hopkins","year":"2008","unstructured":"Hopkins AL. Network pharmacology: the next paradigm in drug discovery. Nat Chem Biol. 2008;4(11):682\u201390. https:\/\/doi.org\/10.1038\/nchembio.118.","journal-title":"Nat Chem Biol"},{"key":"2990_CR21","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1016\/j.jep.2015.07.016","volume":"173","author":"YM Ma","year":"2015","unstructured":"Ma YM, Zhang XZ, Su ZZ, et al. Insight into the molecular mechanism of a herbal injection by integrating network pharmacology and in vitro. J Ethnopharmacol. 2015;173:91\u20139. https:\/\/doi.org\/10.1016\/j.jep.2015.07.016.","journal-title":"J Ethnopharmacol"},{"issue":"3","key":"2990_CR22","doi-asserted-by":"publisher","first-page":"209","DOI":"10.3322\/caac.21660","volume":"71","author":"H Sung","year":"2021","unstructured":"Sung H, Ferlay J, Siegel RL, et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2021;71(3):209\u201349. https:\/\/doi.org\/10.3322\/caac.21660.","journal-title":"CA Cancer J Clin"},{"key":"2990_CR23","doi-asserted-by":"publisher","DOI":"10.1016\/j.blre.2021.100825","author":"AEG Osman","year":"2021","unstructured":"Osman AEG, Deininger MW. Chronic Myeloid Leukemia: modern therapies, current challenges and future directions. Blood Rev. 2021. https:\/\/doi.org\/10.1016\/j.blre.2021.100825.","journal-title":"Blood Rev"},{"issue":"1","key":"2990_CR24","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1186\/s12943-018-0804-2","volume":"17","author":"KS Bhullar","year":"2018","unstructured":"Bhullar KS, Lagar\u00f3n NO, McGowan EM, et al. Kinase-targeted cancer therapies: progress, challenges and future directions. Mol Cancer. 2018;17(1):48. https:\/\/doi.org\/10.1186\/s12943-018-0804-2.","journal-title":"Mol Cancer"},{"issue":"2","key":"2990_CR25","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1016\/j.canlet.2014.03.013","volume":"347","author":"Q Wu","year":"2014","unstructured":"Wu Q, Yang Z, Nie Y, Shi Y, Fan D. Multi-drug resistance in cancer chemotherapeutics: mechanisms and lab approaches. Cancer Lett. 2014;347(2):159\u201366. https:\/\/doi.org\/10.1016\/j.canlet.2014.03.013.","journal-title":"Cancer Lett"},{"issue":"2","key":"2990_CR26","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1530\/JOE-19-0393","volume":"244","author":"B You","year":"2020","unstructured":"You B, Dun Y, Zhang W, et al. Anti-insulin resistance effects of salidroside through mitochondrial quality control. J Endocrinol. 2020;244(2):383\u201393. https:\/\/doi.org\/10.1530\/JOE-19-0393.","journal-title":"J Endocrinol"},{"key":"2990_CR27","doi-asserted-by":"publisher","first-page":"153964","DOI":"10.1016\/j.phymed.2022.153964","volume":"99","author":"H Chen","year":"2022","unstructured":"Chen H, Zhu J, Le Y, et al. Salidroside inhibits doxorubicin-induced cardiomyopathy by modulating a ferroptosis-dependent pathway. Phytomedicine. 2022;99:153964. https:\/\/doi.org\/10.1016\/j.phymed.2022.153964.","journal-title":"Phytomedicine"},{"issue":"7","key":"2990_CR28","doi-asserted-by":"publisher","first-page":"512","DOI":"10.2174\/1389200221666200610172105","volume":"21","author":"SKJ Magani","year":"2020","unstructured":"Magani SKJ, Mupparthi SD, Gollapalli BP, et al. Salidroside: can it be a multifunctional drug? Curr Drug Metab. 2020;21(7):512\u201324. https:\/\/doi.org\/10.2174\/1389200221666200610172105.","journal-title":"Curr Drug Metab"},{"key":"2990_CR29","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2019.109726","author":"L Rong","year":"2020","unstructured":"Rong L, Li Z, Leng X, et al. Salidroside induces apoptosis and protective autophagy in human gastric cancer AGS cells through the PI3K\/Akt\/mTOR pathway. Biomed Pharmacother. 2020. https:\/\/doi.org\/10.1016\/j.biopha.2019.109726.","journal-title":"Biomed Pharmacother"},{"issue":"7","key":"2990_CR30","doi-asserted-by":"publisher","first-page":"1064","DOI":"10.1038\/leu.2011.46","volume":"25","author":"AM Martelli","year":"2011","unstructured":"Martelli AM, Evangelisti C, Chappell W, et al. Targeting the translational apparatus to improve leukemia therapy: roles of the PI3K\/PTEN\/Akt\/mTOR pathway. Leukemia. 2011;25(7):1064\u201379. https:\/\/doi.org\/10.1038\/leu.2011.46.","journal-title":"Leukemia"},{"issue":"11","key":"2990_CR31","doi-asserted-by":"publisher","first-page":"e111814","DOI":"10.1371\/journal.pone.0111814","volume":"9","author":"TC Cheng","year":"2014","unstructured":"Cheng TC, Lai CS, Chung MC, et al. Potent anti-cancer effect of 3\u2019-hydroxypterostilbene in human colon xenograft tumors. PLoS ONE. 2014;9(11):e111814. https:\/\/doi.org\/10.1371\/journal.pone.0111814.","journal-title":"PLoS ONE"},{"issue":"1","key":"2990_CR32","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1158\/1535-7163.MCT-12-0492","volume":"12","author":"R Gowda","year":"2013","unstructured":"Gowda R, Madhunapantula SV, Desai D, Amin S, Robertson GP. Simultaneous targeting of COX-2 and AKT using selenocoxib-1-GSH to inhibit melanoma. Mol Cancer Ther. 2013;12(1):3\u201315. https:\/\/doi.org\/10.1158\/1535-7163.MCT-12-0492.","journal-title":"Mol Cancer Ther"},{"key":"2990_CR33","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1186\/s12964-014-0061-y","volume":"12","author":"MC Hodgson","year":"2014","unstructured":"Hodgson MC, Deryugina EI, Suarez E, et al. INPP4B suppresses prostate cancer cell invasion. Cell Commun Signal. 2014;12:61. https:\/\/doi.org\/10.1186\/s12964-014-0061-y.","journal-title":"Cell Commun Signal"},{"issue":"3","key":"2990_CR34","doi-asserted-by":"publisher","first-page":"417","DOI":"10.3324\/haematol.2013.098442","volume":"99","author":"S Bibi","year":"2014","unstructured":"Bibi S, Arslanhan MD, Langenfeld F, et al. Co-operating STAT5 and AKT signaling pathways in chronic myeloid leukemia and mastocytosis: possible new targets of therapy. Haematologica. 2014;99(3):417\u201329. https:\/\/doi.org\/10.3324\/haematol.2013.098442.","journal-title":"Haematologica"},{"issue":"43","key":"2990_CR35","doi-asserted-by":"publisher","first-page":"25022","DOI":"10.1039\/c9ra01683j","volume":"9","author":"C Ge","year":"2019","unstructured":"Ge C, Zhang J, Feng F. Salidroside enhances the anti-cancerous effect of imatinib on human acute monocytic leukemia\u00a0via\u00a0the induction of autophagy-related apoptosis through AMPK activation. RSC Adv. 2019;9(43):25022\u201333. https:\/\/doi.org\/10.1039\/c9ra01683j.","journal-title":"RSC Adv"},{"issue":"12","key":"2990_CR36","doi-asserted-by":"publisher","first-page":"2337","DOI":"10.1007\/s00018-015-1867-5","volume":"72","author":"J Bertacchini","year":"2015","unstructured":"Bertacchini J, Heidari N, Mediani L, et al. Targeting PI3K\/AKT\/mTOR network for treatment of leukemia. Cell Mol Life Sci. 2015;72(12):2337\u201347. https:\/\/doi.org\/10.1007\/s00018-015-1867-5.","journal-title":"Cell Mol Life Sci"},{"issue":"1","key":"2990_CR37","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1007\/s40291-015-0173-0","volume":"20","author":"S Lakkireddy","year":"2016","unstructured":"Lakkireddy S, Aula S, Kapley A, et al. Association of vascular endothelial growth factor A (VEGFA) and its receptor (VEGFR2) gene polymorphisms with risk of chronic myeloid leukemia and influence on clinical outcome. Mol Diagn Ther. 2016;20(1):33\u201344. https:\/\/doi.org\/10.1007\/s40291-015-0173-0.","journal-title":"Mol Diagn Ther"},{"issue":"6","key":"2990_CR38","doi-asserted-by":"publisher","first-page":"1160","DOI":"10.1038\/sj.leu.2402486","volume":"16","author":"A Janowska-Wieczorek","year":"2002","unstructured":"Janowska-Wieczorek A, Majka M, Marquez-Curtis L, Wertheim JA, Turner AR, Ratajczak MZ. Bcr-abl-positive cells secrete angiogenic factors including matrix metalloproteinases and stimulate angiogenesis in vivo in Matrigel implants. Leukemia. 2002;16(6):1160\u20136. https:\/\/doi.org\/10.1038\/sj.leu.2402486.","journal-title":"Leukemia"},{"issue":"2","key":"2990_CR39","first-page":"89","volume":"1","author":"JM Ebos","year":"2002","unstructured":"Ebos JM, Tran J, Master Z, et al. Imatinib mesylate (STI-571) reduces Bcr-Abl-mediated vascular endothelial growth factor secretion in chronic myelogenous leukemia. Mol Cancer Res. 2002;1(2):89\u201395.","journal-title":"Mol Cancer Res"},{"issue":"12","key":"2990_CR40","doi-asserted-by":"publisher","first-page":"1907","DOI":"10.3390\/biomedicines9121907","volume":"9","author":"PS Wu","year":"2021","unstructured":"Wu PS, Wang CY, Chen PS, Hung JH, Yen JH, Wu MJ. 8-hydroxydaidzein downregulates JAK\/STAT, MMP, oxidative phosphorylation, and PI3K\/AKT pathways in K562 cells. Biomedicines. 2021;9(12):1907. https:\/\/doi.org\/10.3390\/biomedicines9121907.","journal-title":"Biomedicines."},{"issue":"6","key":"2990_CR41","doi-asserted-by":"publisher","first-page":"334","DOI":"10.1179\/1607845413Y.0000000083","volume":"18","author":"X Luo","year":"2013","unstructured":"Luo X, Feng M, Zhu X, Li Y, Fei J, Zhang Y. VEGF depletion enhances bcr-abl-specific sensitivity of arsenic trioxide in chronic myelogenous leukemia. Hematology. 2013;18(6):334\u201340. https:\/\/doi.org\/10.1179\/1607845413Y.0000000083.","journal-title":"Hematology"},{"issue":"20","key":"2990_CR42","doi-asserted-by":"publisher","first-page":"3328","DOI":"10.1016\/j.febslet.2011.09.023","volume":"585","author":"AR Farina","year":"2011","unstructured":"Farina AR, Cappabianca L, DeSantis G, et al. Thioredoxin stimulates MMP-9 expression, de-regulates the MMP-9\/TIMP-1 equilibrium and promotes MMP-9 dependent invasion in human MDA-MB-231 breast cancer cells. FEBS Lett. 2011;585(20):3328\u201336. https:\/\/doi.org\/10.1016\/j.febslet.2011.09.023.","journal-title":"FEBS Lett"},{"issue":"4","key":"2990_CR43","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1158\/1541-7786.MCR-09-0445","volume":"8","author":"A Bruni-Cardoso","year":"2010","unstructured":"Bruni-Cardoso A, Johnson LC, Vessella RL, Peterson TE, Lynch CC. Osteoclast-derived matrix metalloproteinase-9 directly affects angiogenesis in the prostate tumor-bone microenvironment. Mol Cancer Res. 2010;8(4):459\u201370. https:\/\/doi.org\/10.1158\/1541-7786.MCR-09-0445.","journal-title":"Mol Cancer Res"},{"issue":"4","key":"2990_CR44","first-page":"1071","volume":"27","author":"ZK He","year":"2019","unstructured":"He ZK, Xue S, Zhang YH, Li L, Xia YJ, Wang X, Shi X, Liu Y, Xu Z, Li C, Zhang JX. Expression levels of JARID1B, Hes1 and MMP-9 Genes in CML patients treated with imatinib mesylate. Zhongguo Shi Yan Xue Ye Xue Za Zh. 2019;27(4):1071\u20136.","journal-title":"Zhongguo Shi Yan Xue Ye Xue Za Zh"},{"issue":"25","key":"2990_CR45","doi-asserted-by":"publisher","first-page":"3932","DOI":"10.1182\/blood-2013-01-476747","volume":"123","author":"F Nakahara","year":"2014","unstructured":"Nakahara F, Kitaura J, Uchida T, et al. Hes1 promotes blast crisis in chronic myelogenous leukemia through MMP-9 upregulation in leukemic cells. Blood. 2014;123(25):3932\u201342. https:\/\/doi.org\/10.1182\/blood-2013-01-476747.","journal-title":"Blood"},{"issue":"4","key":"2990_CR46","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1093\/jb\/mvr016","volume":"149","author":"X Zhu","year":"2011","unstructured":"Zhu X, Wang L, Zhang B, Li J, Dou X, Zhao RC. TGF-beta1-induced PI3K\/Akt\/NF-kappaB\/MMP9 signalling pathway is activated in Philadelphia chromosome-positive chronic myeloid leukaemia hemangioblasts. J Biochem. 2011;149(4):405\u201314. https:\/\/doi.org\/10.1093\/jb\/mvr016.","journal-title":"J Biochem"},{"issue":"5","key":"2990_CR47","doi-asserted-by":"publisher","first-page":"1249","DOI":"10.3892\/etm.2021.10684","volume":"22","author":"D Chen","year":"2021","unstructured":"Chen D, Luo C. Salidroside inhibits chronic myeloid leukemia cell proliferation and induces apoptosis by regulating the miR-140-5p\/wnt5a\/\u03b2-catenin axis. Exp Ther Med. 2021;22(5):1249. https:\/\/doi.org\/10.3892\/etm.2021.10684.","journal-title":"Exp Ther Med"}],"container-title":["Clinical and Translational Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12094-022-02990-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12094-022-02990-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12094-022-02990-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,1,24]],"date-time":"2023-01-24T17:24:39Z","timestamp":1674581079000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12094-022-02990-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,11,11]]},"references-count":47,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2023,2]]}},"alternative-id":["2990"],"URL":"https:\/\/doi.org\/10.1007\/s12094-022-02990-w","relation":{},"ISSN":["1699-3055"],"issn-type":[{"value":"1699-3055","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,11,11]]},"assertion":[{"value":"25 July 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 August 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 November 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The author declares no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"This article does not contain any studies with human participants or animals performed by any of the authors.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"For this type of study, formal consent is not required.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}]}}